Increased transparency in IARC Monograph programme

[...]we introduced the Policy Watch5 section, in which the key findings of every Monograph meeting are summarised up to 12 months before the corresponding Monograph appears in print. [...]Policy Watch articles have also included a declaration on the conflicts of interest for all IARC authors in acco...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology 2005-10, Vol.6 (10), p.735-735
Main Author: Collingridge, David
Format: Article
Language:English
Subjects:
Boyle, Peter
Conflicts of interest
Health risk assessment
Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]we introduced the Policy Watch5 section, in which the key findings of every Monograph meeting are summarised up to 12 months before the corresponding Monograph appears in print. [...]Policy Watch articles have also included a declaration on the conflicts of interest for all IARC authors in accordance with The Lancet Oncology's rules.8 After the first Policy Watch5 in September, 2004, The Lancet Oncology and IARC agreed to continue discussions on more comprehensive methods of improving transparency in the Monograph programme. The issues encountered by IARC are certainly not unique and we hope that this joint initiative will serve as a model for other health agencies. Because the Monograph programme has wide-ranging and vital public-health implications, The Lancet Oncology commends IARC in the way in which it has responded to criticism, and are pleased to have been given this opportunity to help improve transparency in IARC's flagship initiative.
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(05)70364-8